Search Results - "McCabe, Carolyn"

Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial by Montalescot, Gilles, Prof, Wiviott, Stephen D, MD, Braunwald, Eugene, MD, Murphy, Sabina A, MPH, Gibson, C Michael, MD, McCabe, Carolyn H, BS, Antman, Elliott M, MD

“…Summary Background Mechanical reperfusion with stenting for ST-elevation myocardial infarction (STEMI) is supported by dual antiplatelet treatment with aspirin…”
Get full text

Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48) by Ruff, Christian T., MD, Giugliano, Robert P., MD, SM, Antman, Elliott M., MD, Crugnale, Sharon E., MS, Bocanegra, Tomas, MD, Mercuri, Michele, MD, PhD, Hanyok, James, PharmD, Patel, Indravadan, MD, Shi, Minggao, PhD, Salazar, Dan, PhD, McCabe, Carolyn H., BS, Braunwald, Eugene, MD

“…Background Vitamin K antagonists have been the standard oral antithrombotic used for more than a half century for prevention and treatment of thromboembolism…”
Get full text

Metabolomics of Diabetes in Pregnancy by McCabe, Carolyn F., Perng, Wei

“…Purpose of review The purpose of this review is to describe ways in which metabolomics may enhance understanding of gestational diabetes mellitus (GDM)…”
Get full text

Diabetes and Mortality Following Acute Coronary Syndromes by Donahoe, Sean M, Stewart, Garrick C, McCabe, Carolyn H, Mohanavelu, Satishkumar, Murphy, Sabina A, Cannon, Christopher P, Antman, Elliott M

“…CONTEXT The worldwide epidemic of diabetes mellitus is increasing the burden of cardiovascular disease, the leading cause of death among persons with diabetes…”
Get full text

Cultural Competency Training and Evaluation Methods Across Dietetics Education: A Narrative Review by McCabe, Carolyn F., O’Brien-Combs, Amelia, Anderson, Olivia S.

“…Developing cultural competence among credentialed nutrition and dietetics practitioners is critical to move toward eliminating disparities in health care…”
Get full text

Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes by Wiviott, Stephen D, Braunwald, Eugene, McCabe, Carolyn H, Montalescot, Gilles, Ruzyllo, Witold, Gottlieb, Shmuel, Neumann, Franz-Joseph, Ardissino, Diego, De Servi, Stefano, Murphy, Sabina A, Riesmeyer, Jeffrey, Weerakkody, Govinda, Gibson, C. Michael, Antman, Elliott M

“…Antiplatelet therapy with aspirin and a thienopyridine is a key component in the management of acute coronary syndromes. This trial compared a novel, potent…”
Get full text

Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial by Wiviott, Stephen D, Dr, Braunwald, Eugene, MD, McCabe, Carolyn H, BS, Horvath, Ivan, MD, Keltai, Matyas, MD, Herrman, Jean-Paul R, MD, Van de Werf, Frans, MD, Downey, William E, MD, Scirica, Benjamin M, MD, Murphy, Sabina A, MPH, Antman, Elliott M, MD

“…Summary Background Intracoronary stenting can improve procedural success and reduce restenosis compared with balloon angioplasty in patients with acute…”
Get full text

Home environment factors associated with child BMI changes during COVID-19 pandemic by McCabe, Carolyn F, Wood, G Craig, Welk, Gregory J, Cook, Adam, Franceschelli-Hosterman, Jennifer, Bailey-Davis, Lisa

“…The influence of home obesogenic environments, as assessed by the validated Family Nutrition and Physical Activity (FNPA) tool, and child obesity during the…”
Get full text

Early and Late Benefits of Prasugrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention : A TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) Analysis by ANTMAN, Elliott M, WIVIOTT, Stephen D, MURPHY, Sabina A, VOITK, Juri, HASIN, Yonathan, WIDIMSKY, Petr, CHANDNA, Harish, MACIAS, William, MCCABE, Carolyn H, BRAUNWALD, Eugene

“…We evaluated the relative contributions of the loading and maintenance doses of prasugrel on events in a TRITON-TIMI 38 (TRial to Assess Improvement in…”
Get full text

Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38 by WIVIOTT, Stephen D, BRAUNWALD, Eugene, MCCABE, Carolyn H, ANTMAN, Elliott M, ANGIOLILLO, Dominick J, MEISEL, Simha, DALBY, Anthony J, VERHEUGT, Freek W. A, GOODMAN, Shaun G, CORBALAN, Ramon, PURDY, Drew A, MURPHY, Sabina A

“…Patients with diabetes mellitus (DM) are at high risk for recurrent cardiovascular events after acute coronary syndromes, in part because of increased platelet…”
Get full text

C-Reactive Protein Levels and Outcomes after Statin Therapy by Ridker, Paul M, Cannon, Christopher P, Morrow, David, Rifai, Nader, Rose, Lynda M, McCabe, Carolyn H, Pfeffer, Marc A, Braunwald, Eugene

“…Statin therapy lowers not only low-density lipoprotein (LDL) cholesterol levels, but also levels of C-reactive protein (CRP), a marker of inflammation. This…”
Get full text

Early and Late Benefits of Prasugrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention by Antman, Elliott M., MD, FACC, Wiviott, Stephen D., MD, Murphy, Sabina A., MPH, Voitk, Juri, MD, FACC, Hasin, Yonathan, MD, Widimsky, Petr, MD, DrSc, Chandna, Harish, MBBS, FACC, Macias, William, MD, PhD, McCabe, Carolyn H., BS, Braunwald, Eugene, MD, MACC

“…Early and Late Benefits of Prasugrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: A TRITON–TIMI 38 (TRial to Assess…”
Get full text

Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) trial by Murphy, Sabina A, Cannon, Christopher P, Wiviott, Stephen D, McCabe, Carolyn H, Braunwald, Eugene

“…In addition to reducing first events in patients after an acute coronary syndrome (ACS), we hypothesized that high-dose atorvastatin 80 mg would also reduce…”
Get full text

Prasugrel Compared With High Loading-and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention : The Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 Trial by WIVIOTT, Stephen D, TRENK, Dietmar, JAKUBOWSKI, Joseph A, CAIRNS, Richard, MURPHY, Sabina A, MCCABE, Carolyn H, ANTMAN, Elliott M, BRAUNWALD, Eugene, FRELINGER, Andrew L, O'DONOGHUE, Michelle, NEUMANN, Franz-Josef, MICHELSON, Alan D, ANGIOLILLO, Dominick J, HOD, Hanoch, MONTALESCOT, Gilles, MILLER, Debra L

“…The increasing use of higher-than-approved doses of clopidogrel in clinical practice is based in part on the desire for greater levels of inhibition of…”
Get full text

Childhood Obesity and Early Body Mass Index Gains Associated with COVID-19 in a Large Rural Health System by McCabe, Carolyn F., Wood, G. Craig, Franceschelli-Hosterman, Jennifer, Bailey-Davis, Lisa

“…To evaluate body mass index (BMI) change among a population of children with a high proportion residing in rural areas across two pandemic time periods…”
Get full text

Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial by Michelson, Alan D., Frelinger, Andrew L., Braunwald, Eugene, Downey, William E., Angiolillo, Dominick J., Xenopoulos, Nicholas P., Jakubowski, Joseph A., Li, Youfu, Murphy, Sabina A., Qin, Jie, McCabe, Carolyn H., Antman, Elliott M., Wiviott, Stephen D.

“…Aims To examine the extent of platelet inhibition by prasugrel vs. clopidogrel in a TRITON-TIMI 38 substudy. Methods and results TRITON-TIMI 38 randomized…”
Get full text

Probing prenatal bisphenol exposures and tissue-specific DNA methylation responses in cord blood, cord tissue, and placenta by McCabe, Carolyn F., Goodrich, Jaclyn M., Bakulski, Kelly M., Domino, Steven E., Jones, Tamara R., Colacino, Justin, Dolinoy, Dana C., Padmanabhan, Vasantha

“…The early-gestational fetal epigenome establishes the landscape for fetal development and is susceptible to disruption via environmental stressors including…”
Get full text

Effects of Ranolazine on Recurrent Cardiovascular Events in Patients With Non–ST-Elevation Acute Coronary Syndromes: The MERLIN-TIMI 36 Randomized Trial by Morrow, David A, Scirica, Benjamin M, Karwatowska-Prokopczuk, Ewa, Murphy, Sabina A, Budaj, Andrzej, Varshavsky, Sergei, Wolff, Andrew A, Skene, Allan, McCabe, Carolyn H, Braunwald, Eugene, MERLIN-TIMI 36 Trial Investigators, For the

“…CONTEXT Ranolazine is a novel antianginal agent that reduces ischemia in patients with chronic angina but has not been studied in patients with acute coronary…”
Get full text

Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with Non-ST-Segment-Elevation acute coronary syndrome : Results from the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndrome-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) randomized controlled trial by SCIRICA, Benjamin M, MORROW, David A, BRAUNWALD, Eugene, HOD, Hanoch, MURPHY, Sabina A, BELARDINELLI, Luiz, HEDGEPETH, Chester M, MOLHOEK, Peter, VERHEUGT, Freek W. A, GERSH, Bernard J, MCCABE, Carolyn H

“…Ranolazine, a piperazine derivative, reduces ischemia via inhibition of the late phase of the inward sodium current (late I(Na)) during cardiac repolarization,…”
Get full text

Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): Comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes by Cannon, Christopher P., MD, Giugliano, Robert P., MD, SM, Blazing, Michael A., MD, Harrington, Robert A., MD, Peterson, John L., MD, Sisk, Christine McCrary, BS, Strony, John, MD, Musliner, Thomas A., MD, McCabe, Carolyn H., BS, Veltri, Enrico, MD, Braunwald, Eugene, MD, Califf, Robert M., MD

“…Background Reduction in low-density lipoprotein cholesterol (LDL-C) improves clinical outcomes in patients with chronic coronary artery disease and acute…”
Get full text